RecruitingNot ApplicableNCT06727292

Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo


Sponsor

Finzelberg GmbH & Co. KG

Enrollment

66 participants

Start Date

Oct 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this clinical trial is to evaluate whether nutritional supplementation over a 2-month period improves skin physiological parameters. This is a national, single-center, double-blind, randomized pilot study. The study will be conducted using a supplement and a placebo, the safety of which has been assured by the sponsor. Participants will: * Take a food supplement or a placebo once daily for 2 months * Visit the study center at beginning, after 28 days and after 56 days of supplementation. * Keep a diary of their skin status and tolerability The secondary objective is to evaluate product characteristics and performance during normal use in healthy subjects.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 65 Years

Inclusion Criteria11

  • Phototype: I to IV;
  • Subjects with normal to dry skin;
  • Subjects with healthy skin on the study area;
  • Non-smokers;
  • Has normal nutritional habits (not vegetarian/vegan);
  • Is not pregnant or lactating;
  • Has a BMI of 18 - 33 kg/m2;
  • Is willing to refrain from taking dietary supplements (at best not at all, in any case not during the last month before study start);
  • Willing not to use any oral products or any nutritional supplementation aiming at improving skin status during the course of the study;
  • No history of malabsorption diseases, liver diseases, or diseases of the lipid metabolism;
  • Uses no medication, which may interact with the study product

Exclusion Criteria15

  • For women: pregnant or nursing woman or woman planning to get pregnant during the study;
  • Cutaneous pathology on the study zone (eczema, etc.);
  • Subject with make-up on the day of the visit at the laboratory;
  • Use of topical or systemic treatment during the previous weeks liable to interfere with the assessment of the efficacy of the study product:
  • change in anti-wrinkle, smoothing and/or firming topical products within previous week on the studied zones,
  • non-invasive procedures within previous month on the studied zones,
  • intake of food supplement acting on skin within the three previous months,
  • invasive procedures:
  • deep chemical peeling within previous 3 months on the studied zones,
  • mesotherapy, dermapen, laser within previous 6 months on the studied zones,
  • botox and/or hyaluronic acid injections within previous 12 months on the studied zones;
  • Intake of vitamin substances and diets comprising a change of normal eating habits;
  • Known allergy to one or several investigational product´s ingredients;
  • Participation in a nutritional study within the last 30 days;
  • Surgical or internal diseases e.g. a metabolic or endocrine disease that may affect the outcome of the study (e.g. diabetes, liver diseases, kidney disorders) or having a history of medical or surgical events that may significantly affect the study outcome including any cardiovascular disease, skin disease, hypertension (>140/90 mm Hg in three repeated measurements).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTFood supplement

Instant drink in a powder form presented in a sachet to be disolved in a glass of water (200 ml).

DIETARY_SUPPLEMENTPlacebo

Instant drink in powder form in a sachet to be disolved in a glass of water (200ml)


Locations(1)

Eurofins Dermscan Poland

Gdansk, GDANSK, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06727292


Related Trials